Cargando…
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
The metalloproteinase (MP) family of zinc-dependent proteases, including matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs), and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) plays a crucial role in the extracellular matrix (ECM) remodeling and de...
Autores principales: | Raeeszadeh-Sarmazdeh, Maryam, Do, Linh D., Hritz, Brianne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290391/ https://www.ncbi.nlm.nih.gov/pubmed/32466129 http://dx.doi.org/10.3390/cells9051313 |
Ejemplares similares
-
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2017) -
Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10
por: Raeeszadeh-Sarmazdeh, Maryam, et al.
Publicado: (2022) -
The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
por: Herszényi, László, et al.
Publicado: (2012) -
Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics
por: Nagase, Hideaki, et al.
Publicado: (2002) -
Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye
por: Fini, M. Elizabeth, et al.
Publicado: (2020)